Patents-Review.com
🔗 Permalink
Assignee profile:

Clarus Therapeutics, Inc.

City:

Northbrook, Illinois

Country:

United States

Published Applications:

15

Last publication date:

2020-03-26

Patent Grants:

12

Last grant date:

2022-08-30

Top Inventors for applications by Clarus Therapeutics, Inc.

These are the the leading inventors for applications assigned to Clarus Therapeutics, Inc.:

Recent patent applications by Clarus Therapeutics, Inc.

Clarus Therapeutics, Inc. based in Northbrook, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-03-26 ✅ Patent 11,426,416 granted on 2022-08-30
US20200093836A1
Human necessities

Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same

 #2 | 2020-02-13 ✅ Patent 11,331,325 granted on 2022-05-17
US20200046733A1
Human necessities

Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same

 #3 | 2020-02-13 ✅ Patent 11,179,403 granted on 2021-11-23
US20200046732A1
Human necessities

Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same

 #4 | 2018-04-26 ✅ Patent 10,543,219 granted on 2020-01-28
US20180110786A1
Human necessities

Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same

 #5 | 2018-03-15 ✅ Patent 11,179,402 granted on 2021-11-23
US20180071311A1
Human necessities

Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same

 #6 | 2017-04-20 ✅ Patent 10,617,696 granted on 2020-04-14
US20170106002A1
Human necessities

Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same

 #7 | 2016-11-03 ✅ Patent 10,245,273 granted on 2019-04-02
US20160317553A1
Human necessities

Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agents

 #8 | 2014-10-09
US20140303129A1
Human necessities

METHODS OF TREATING TESTOSTERONE DEFICIENCY

 #9 | 2014-09-18
US20140274986A1
Human necessities

ORAL TESTOSTERONE ESTER FORMULATIONS AND METHODS OF TREATING TESTOSTERONE DEFICIENCY COMPRISING SAME

 #10 | 2014-09-04 ✅ Patent 8,828,428 granted on 2014-09-09
US20140249124A1
Human necessities

Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same

 #11 | 2014-01-09 ✅ Patent 8,778,917 granted on 2014-07-15
US20140011789A1
Human necessities

Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same

 #12 | 2013-01-24
US20130022674A1
Human necessities

PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME

 #13 | 2012-12-06 ✅ Patent 8,778,916 granted on 2014-07-15
US20120309731A1
Human necessities

Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same

 #14 | 2011-10-13 ✅ Patent 8,492,369 granted on 2013-07-23
US20110251167A1
Human necessities

Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same

 #15 | 2008-12-25 ✅ Patent 8,241,664 granted on 2012-08-14
US20080317844A1
Human necessities

Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same

Also check out Clarus Therapeutics, Inc.'s (Northbrook, United States) applicant profile with 9 patent applications submitted.

AssigneeID:

5892 ⎘